Fight the New Drug Inc (EIN 263550143) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2008

Legal Domicile

Principal Officer

Natale McAneney

Phone

3854048811

Tax Period

2025-01-01 to 2025-12-31

Fight the New Drug Inc, founded in 2008, is a small nonprofit in the Mental Health sector that reported $902K in total revenue in fiscal year 2025. Expenses of $1.0M exceeded revenue, resulting in a 12% operating deficit.

Mission

Fight the New Drug is a non-religious and non-legislative organization that exists to provide individuals the opportunity to make an informed decision regarding pornography by raising awareness on its harmful effects using only science, facts, and personal accounts.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $816,392

Program Service Revenue $35,218

Investment Income $768

Other Revenue $49,179

TOTAL REVENUE $901,557

Expense Breakdown

Grants Paid $0

Salaries & Benefits $768,167

Fundraising Expenses $37,531

Program Expenses $915,747

Other Expenses $245,031

TOTAL EXPENSES $1,013,198

Year-over-Year Comparison

	2025	2024	Change
Revenue	$901,557	$841,023	+0.1%
Expenses	$1,013,198	$1,166,542	-0.1%
Net Income	$-111,641	$-325,519	-0.7%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$112,391

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Kacie Malouf	Chair	1.00	Officer Director	$0	$0	$0
Sam Malouf	Board Member	1.00	Director	$0	$0	$0
Clay Olsen	Board Member	1.00	Officer Director	$0	$0	$0
Elizabeth Smart	Secretary	1.00	Director	$0	$0	$0
Louie Greek	Board Member	1.00	Director	$0	$0	$0
Dr Brook Parker-Bello	Board Member	1.00	Director	$0	$0	$0
Natale McAneney	Executive Director	40.00	Officer	$107,775	$4,616	$112,391

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$901,557	$1,013,198	$141,584	$-111,641
2024	No data	No data	No data	No data
2023	$697,836	$1,227,127	$356,635	$-529,291
2022	$1,439,055	$1,549,197	$827,817	$-110,142
2021	$1,518,548	$1,573,323	$878,104	$-54,775
2020	$1,613,007	$1,549,949	$946,738	$63,058
2019	$410,312	$1,627,339	$867,208	$-1,217,027
2018	$1,462,942	$1,518,320	$2,097,816	$-55,378

Fight the New Drug Inc